Results 31 to 40 of about 4,993,363 (331)

Mycophenolic acid

open access: yesReactions weekly, 2020
An antineoplastic antibiotic derived from various Penicillium fungal species. Mycophenolic acid is an active metabolite of the prodrug mycophenolate mofetil. Mycophenolic acid inhibits inosine monophosphate dehydrogenase (IMPDH), preventing the formation

semanticscholar   +2 more sources

Mycophenolate-induced eosinophilic colitis: A case report

open access: yesIatreia, 2023
Mycophenolate mofetil is a medication used for the prevention of allograft rejection in organ transplant patients. Eosinophilic colitis due to mycophenolate is a recognized condition in patients with a history of renal transplantation and persistent ...
Mario Alberto Caviedes-Cleves   +1 more
doaj   +1 more source

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study

open access: yesFrontiers in Public Health, 2021
Background: Organ transplantations are difficult, complicated and very expensive interventions. In order to preserve the transplanted organs, it is necessary to provide medical care to the patients in terms of immunosuppression.
Majda Sahman   +5 more
doaj   +1 more source

Antiviral activities of mycophenolic acid and IMD‐0354 against SARS‐CoV‐2

open access: yesMicrobiology and immunology, 2020
In this study, the anti–severe acute respiratory syndrome coronavirus‐2 (anti‐SARS‐CoV‐2) activity of mycophenolic acid (MPA) and IMD‐0354 was analyzed. These compounds were chosen based on their antiviral activities against other coronaviruses.
Fumihiro Kato   +5 more
semanticscholar   +1 more source

Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil [PDF]

open access: yesEncephalitis, 2021
Sweet syndrome, or acute febrile neutrophilic dermatosis, is mainly a dermatologic condition presenting with erythematous plaques; however, neutrophils infiltrate multiple systems. Neuro-Sweet disease is a neurological manifestation of Sweet syndrome and
Sungeun Hwang   +7 more
doaj   +1 more source

Levels of donor‐derived cell‐free DNA and chemokines in BK polyomavirus‐associated nephropathy

open access: yesClinical Transplantation, Volume 36, Issue 11, November 2022., 2022
Abstract Background BK polyomavirus‐associated nephropathy (BKPyVAN) carries a risk of irreversible allograft injury. While detection of BK viremia and biopsy assessment are the current diagnostic gold standard, the diagnostic value of biomarkers reflecting tissue injury (donor‐derived cell‐free DNA [dd‐cfDNA]) or immune activation (C‐X‐C motif ...
Katharina A. Mayer   +14 more
wiley   +1 more source

Improved surgical outcomes following simultaneous pancreas‐kidney transplantation in the contemporary era

open access: yesClinical Transplantation, Volume 36, Issue 11, November 2022., 2022
Abstract Background Complications leading to early technical failure have been the Achilles’ heel of simultaneous pancreas‐kidney transplantation (SPKT). The study purpose was to analyze longitudinally our experience with early surgical complications following SPKT with an emphasis on changes in practice that improved outcomes in the most recent era ...
Berjesh Sharda   +9 more
wiley   +1 more source

In vitro rumen simulations show a reduced disappearance of deoxynivalenol, nivalenol and enniatin B at conditions of rumen acidosis and lower microbial activity [PDF]

open access: yes, 2020
Ruminants are generally considered to be less susceptible to the effects of mycotoxins than monogastric animals as the rumen microbiota are capable of detoxifying some of these toxins.
Cools, An   +6 more
core   +2 more sources

CAQ Corner: Basic concepts of transplant immunology

open access: yes, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Factors associated with the severity of COVID‐19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID‐19 Registry

open access: yesEuropean Journal of Neurology, Volume 30, Issue 2, Page 399-412, February 2023., 2023
Abstract Background and purpose Clinical outcome information on patients with neuromuscular diseases (NMDs) who have been infected with SARS‐CoV‐2 is limited. The aim of this study was to determine factors associated with the severity of COVID‐19 outcomes in people with NMDs.
Chiara Pizzamiglio   +93 more
wiley   +1 more source

Home - About - Disclaimer - Privacy